Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2024)
Top biotech stocks in 2024 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology

Overview Zen Score Price Valuation Financials

Forecast Earnings & Revenue Dividends Ownership Technicals

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
INCY	INCYTE CORP	$11.62B	12.40%	9.50%	15.10%	46.10%	0.31	3.75	93.10%	16.20%	22.64%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$1.66B	27.50%	16.80%	30.44%	50.60%	0.74	2.75	79.20%	22.10%	33.87%
VYGR	VOYAGER THERAPEUTICS INC	$411.06M	63.90%	40.80%	42.55%	106.20%	0.49	4.96	100.00%	52.90%	48.81%
AMLX	AMYLYX PHARMACEUTICALS INC	$127.43M	12.40%	10.70%	12.47%	22.80%	0.19	5.66	93.30%	12.90%	14.26%
UTHR	UNITED THERAPEUTICS CORP	$11.15B	17.70%	14.50%	20.96%	22.90%	0.20	4.41	88.90%	42.30%	57.30%
CORT	CORCEPT THERAPEUTICS INC	$2.33B	22.00%	17.90%	20.63%	34.40%	0.23	4.39	98.70%	21.90%	22.11%
PBYI	PUMA BIOTECHNOLOGY INC	$232.84M	58.20%	10.40%	27.45%	31.30%	3.31	1.57	73.40%	9.20%	15.28%
EXEL	EXELIXIS INC	$7.19B	8.60%	6.80%	10.11%	10.70%	0.30	3.34	96.00%	11.40%	14.07%
HALO	HALOZYME THERAPEUTICS INC	$4.96B	204.80%	15.80%	22.65%	17.70%	19.68	6.64	76.80%	34.00%	44.27%
RPRX	ROYALTY PHARMA PLC	$16.72B	11.50%	6.80%	8.15%	6.20%	0.62	7.90	100.00%	48.20%	56.15%
ROIV	ROIVANT SCIENCES LTD	$8.78B	196.20%	128.50%	64.37%	590.00%	0.12	27.79	87.60%	3,624.10%	3,691.45%
TGTX	TG THERAPEUTICS INC	$2.16B	12.90%	4.70%	9.31%	12.00%	1.05	5.92	94.00%	5.40%	10.99%
MDXG	MIMEDX GROUP INC	$944.94M	205.30%	30.10%	14.44%	27.90%	0.68	3.57	83.00%	18.10%	8.67%
GMAB	GENMAB A	$18.81B	14.70%	13.10%	21.49%	38.10%	0.12	13.34	98.60%	26.40%	42.80%
MEIP	MEI PHARMA INC	$21.72M	39.70%	18.30%	28.15%	27.70%	0.32	8.23	100.00%	27.30%	27.32%
BMRN	BIOMARIN PHARMACEUTICAL INC	$17.21B	3.50%	2.50%	3.63%	3.60%	0.38	2.51	78.70%	6.90%	8.51%
BNTX	BIONTECH SE	$20.94B	4.60%	4.20%	5.78%	16.10%	0.14	9.43	84.30%	24.40%	31.68%
VNDA	VANDA PHARMACEUTICALS INC	$262.37M	0.50%	0.40%	1.13%	2.00%	0.19	4.94	92.30%	1.30%	3.29%
DBVT	DBV TECHNOLOGIES SA	$133.27M	-46.40%	-35.30%	-49.93%	-670.90%	0.31	4.26	100.00%	-462.40%	-462.35%
PLX	PROTALIX BIOTHERAPEUTICS INC	$88.39M	29.70%	10.20%	26.89%	24.60%	1.52	1.54	64.90%	12.70%	15.97%
AVRO	AVROBIO INC	$53.38M	13.00%	11.30%	10.68%	396.50%	0.07	15.78	N/A	N/A	N/A
BNOX	BIONOMICS LIMITED	$10.94M	-80.80%	-65.20%	-89.96%	28,812.60%	0.34	3.81	100.00%	-140,642.50%	-140,487.81%
SPRO	SPERO THERAPEUTICS INC	$76.49M	32.60%	18.20%	17.49%	130.70%	0.71	3.53	100.00%	22.00%	24.48%
KRYS	KRYSTAL BIOTECH INC	$4.50B	1.60%	1.50%	1.64%	3.20%	0.05	17.77	93.90%	21.60%	25.44%
CRSP	CRISPR THERAPEUTICS AG	$4.47B	-8.40%	-7.00%	-7.11%	-8.10%	0.18	17.54	100.00%	-41.40%	-40.60%
CPRX	CATALYST PHARMACEUTICALS INC	$1.78B	19.80%	16.50%	23.98%	190.70%	0.21	2.88	86.90%	17.90%	23.73%
KNSA	KINIKSA PHARMACEUTICALS LTD	$1.26B	3.40%	2.90%	-3.60%	-5.20%	0.20	4.34	87.60%	5.20%	-6.16%
IGMS	IGM BIOSCIENCES INC	$467.94M	-103.20%	-53.50%	-64.51%	-78.50%	1.08	8.18	100.00%	-11,568.80%	-11,537.00%
TFFP	TFF PHARMACEUTICALS INC	$7.58M	-163.10%	-144.80%	-221.31%	-476.70%	0.26	3.13	100.00%	-2,894.70%	-2,894.68%
OCUP	OCUPHIRE PHARMA INC	$37.96M	-22.30%	-20.30%	-19.99%	-544.60%	0.08	13.35	100.00%	-52.40%	-52.36%
SEER	SEER INC	$114.65M	-20.90%	-19.00%	-20.39%	-20.30%	0.10	25.00	51.10%	-517.80%	-517.84%
NVO	NOVO NORDISK A S	$568.98B	90.50%	29.20%	72.53%	130.90%	1.95	0.82	84.60%	36.00%	45.23%
ADAG	ADAGENE INC	$121.32M	-24.70%	-14.10%	-19.16%	148.00%	0.64	3.61	100.00%	-104.60%	-89.15%
AXSM	AXSOME THERAPEUTICS INC	$3.37B	-112.40%	-43.70%	-51.59%	-138.50%	2.08	3.63	90.40%	-88.40%	-85.67%
MIRM	MIRUM PHARMACEUTICALS INC	$1.13B	-88.60%	-31.50%	-26.33%	-48.60%	1.60	4.45	74.80%	-87.70%	-79.04%
REGN	REGENERON PHARMACEUTICALS INC	$99.50B	16.10%	12.60%	14.41%	15.70%	0.27	5.69	86.20%	30.10%	32.57%
FULC	FULCRUM THERAPEUTICS INC	$450.89M	-36.60%	-33.60%	-39.89%	-38.20%	0.10	17.71	100.00%	-3,470.10%	-3,470.05%
VYNE	VYNE THERAPEUTICS INC	$36.23M	-79.10%	-64.20%	-31.56%	-217.40%	0.10	12.73	100.00%	-6,710.40%	-6,710.38%
VTGN	VISTAGEN THERAPEUTICS INC	$127.56M	-72.10%	-61.30%	-25.27%	-922.40%	0.06	30.76	100.00%	-3,076.60%	-3,076.34%
IMMP	IMMUTEP LTD	$307.91M	-42.10%	-38.60%	-34.53%	-1,232.30%	0.07	17.24	100.00%	-602.00%	-601.76%
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$61.96M	-22.20%	-18.80%	-24.33%	-66.60%	0.20	8.62	81.80%	-64.00%	-68.55%
TECH	BIO-TECHNE CORP	$9.98B	11.50%	8.40%	10.12%	18.30%	0.39	4.37	67.10%	19.60%	22.94%
IDYA	IDEAYA BIOSCIENCES INC	$2.97B	-23.00%	-21.80%	-18.15%	-30.20%	0.05	19.65	100.00%	-483.00%	-483.05%
RNA	AVIDITY BIOSCIENCES INC	$2.00B	-39.70%	-35.00%	-38.74%	-50.00%	0.26	7.58	100.00%	-2,219.90%	-2,219.87%
PRTA	PROTHENA CORP PUBLIC LTD CO	$1.10B	-24.80%	-20.20%	-25.09%	-963.10%	0.24	11.24	100.00%	-160.90%	-175.64%
AGIO	AGIOS PHARMACEUTICALS INC	$1.78B	-38.10%	-33.70%	-40.51%	-35.90%	0.16	12.27	89.30%	-1,312.60%	-1,312.63%
JAZZ	JAZZ PHARMACEUTICALS PLC	$6.75B	11.80%	3.70%	5.93%	8.20%	2.05	2.24	88.60%	10.80%	15.24%
MDWD	MEDIWOUND LTD	$162.21M	-20.20%	-10.10%	-8.34%	-11.80%	1.10	4.59	19.10%	-35.90%	-24.83%
GNFT	GENFIT SA	$173.92M	-35.60%	-14.80%	-16.91%	-30.40%	1.56	2.94	100.00%	-75.70%	-59.99%
LPCN	LIPOCINE INC	$23.60M	-63.30%	-58.30%	-80.27%	-76.90%	0.13	8.69	100.00%	573.60%	573.57%
KZR	KEZAR LIFE SCIENCES INC	$58.31M	-45.90%	-40.00%	-49.30%	-44.10%	0.18	11.66	100.00%	-1,455.30%	-1,433.14%
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$726.17M	-10.10%	-6.60%	-12.80%	-105.70%	0.54	4.72	100.00%	-17.80%	-26.67%
INM	INMED PHARMACEUTICALS INC	$1.84M	-54.30%	-46.20%	-46.76%	-379.90%	0.19	7.03	38.40%	-115.80%	-115.69%
ALGS	ALIGOS THERAPEUTICS INC	$62.73M	-116.40%	-75.40%	-69.05%	-1,017.50%	0.65	5.90	100.00%	-564.60%	-567.50%
ORMP	ORAMED PHARMACEUTICALS INC	$96.03M	3.60%	2.90%	4.52%	4.20%	0.35	3.06	100.00%	412.30%	564.33%
QURE	UNIQURE NV	$218.14M	-99.30%	-37.70%	-34.96%	-32.80%	3.01	8.85	14.00%	-1,947.10%	-1,672.66%
ANIX	ANIXA BIOSCIENCES INC	$101.44M	-42.40%	-40.90%	-45.31%	-48.80%	0.07	15.19	23.30%	-5,116.20%	-5,116.19%
GBIO	GENERATION BIO CO	$198.77M	-52.30%	-31.80%	-37.81%	-36.50%	0.85	6.83	100.00%	-2,144.50%	-2,144.51%
ZLAB	ZAI LAB LTD	$1.55B	-37.10%	-30.70%	-40.16%	-273.40%	0.30	4.63	64.10%	-125.50%	-125.46%
LIFE	ATYR PHARMA INC	$108.40M	-49.70%	-39.10%	-48.34%	-45.70%	0.33	6.27	100.00%	-14,274.50%	-14,274.50%
XCUR	EXICURE INC	$4.45M	34.50%	13.10%	20.31%	25.00%	0.81	2.56	100.00%	12.90%	13.76%
LEGN	LEGEND BIOTECH CORP	$8.22B	-44.60%	-30.40%	-30.53%	-73.10%	0.48	6.92	49.40%	-181.80%	-174.76%
PTGX	PROTAGONIST THERAPEUTICS INC	$1.50B	-27.50%	-25.30%	-23.45%	-83.60%	0.06	16.71	100.00%	-131.60%	-131.59%
GLPG	GALAPAGOS NV	$1.90B	8.00%	4.70%	5.63%	6.20%	0.56	9.02	100.00%	88.30%	92.32%
MORF	MORPHIC HOLDING INC	$1.39B	-23.60%	-22.90%	-21.74%	-27.70%	0.04	28.94	100.00%	-29,192.90%	-29,119.96%
SAGE	SAGE THERAPEUTICS INC	$841.49M	-58.00%	-52.40%	-67.73%	-67.30%	0.10	10.51	97.50%	-626.30%	-626.32%
FATE	FATE THERAPEUTICS INC	$426.72M	-38.20%	-28.40%	-34.45%	-28.10%	0.37	8.48	100.00%	-253.30%	-253.30%
BOLT	BOLT BIOTHERAPEUTICS INC	$45.75M	-51.20%	-37.80%	-49.66%	-40.20%	0.42	5.17	100.00%	-878.60%	-878.58%
MRUS	MERUS NV	$2.43B	-50.60%	-37.60%	-43.03%	-86.50%	0.28	5.34	100.00%	-352.60%	-378.31%
ACIU	AC IMMUNE SA	$235.10M	-37.50%	-33.30%	-31.94%	-105.20%	0.14	9.22	100.00%	-366.40%	-365.16%
SLGL	SOL-GEL TECHNOLOGIES LTD	$25.63M	-62.60%	-54.70%	-66.82%	-112.20%	0.17	9.10	100.00%	-1,752.80%	-1,752.77%
NRBO	NEUROBO PHARMACEUTICALS INC	$15.21M	-59.40%	-45.40%	-74.13%	215.70%	0.37	3.78	N/A	N/A	N/A
ABIO	ARCA BIOPHARMA INC	$52.64M	-13.80%	-13.30%	-14.34%	7,095.00%	0.02	59.01	N/A	N/A	N/A
FUSN	FUSION PHARMACEUTICALS INC	$1.81B	-46.60%	-35.30%	-32.99%	-34.50%	0.29	15.01	100.00%	-4,588.80%	-4,300.97%
ARGX	ARGENX SE	$22.20B	-8.50%	-7.70%	-7.37%	-15.80%	0.11	9.75	-231.60%	-830.40%	-854.39%
SNSE	SENSEI BIOTHERAPEUTICS INC	$24.87M	-44.00%	-38.60%	-49.41%	-43.30%	0.15	11.92	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$5.93M	-36.40%	-33.70%	-42.21%	-419.10%	0.08	11.84	100.00%	-162.80%	-162.78%
BCYC	BICYCLE THERAPEUTICS PLC	$965.43M	-57.80%	-34.10%	-33.46%	-244.40%	0.61	8.08	100.00%	-669.70%	-652.22%
JANX	JANUX THERAPEUTICS INC	$2.49B	-17.90%	-16.00%	-15.87%	-16.70%	0.11	26.80	100.00%	-721.20%	-721.18%
MRKR	MARKER THERAPEUTICS INC	$39.17M	-50.10%	-38.10%	-58.59%	-143.70%	0.22	5.57	100.00%	-248.80%	-248.65%
ZVRA	ZEVRA THERAPEUTICS INC	$198.02M	-68.40%	-35.20%	-45.18%	-73.00%	1.79	1.18	89.30%	-167.70%	-162.22%
EDIT	EDITAS MEDICINE INC	$437.70M	-43.00%	-30.50%	-39.18%	-50.00%	0.43	5.39	100.00%	-196.10%	-218.61%
CLNN	CLENE INC	$43.28M	-362.00%	-89.80%	-166.40%	-122.70%	2.91	1.53	81.50%	-7,569.40%	-6,872.48%
VERV	VERVE THERAPEUTICS INC	$550.21M	-39.30%	-30.90%	-27.92%	-35.30%	0.26	17.24	100.00%	-1,701.50%	-1,699.21%
TRAW	TRAWS PHARMA INC	$13.49M	-113.20%	-65.80%	-140.74%	240.20%	1.13	2.46	100.00%	-8,384.10%	-8,384.07%
ALT	ALTIMMUNE INC	$501.94M	-52.00%	-47.30%	-44.54%	-153.20%	0.09	17.26	100.00%	-20,762.20%	-20,753.99%
RYTM	RHYTHM PHARMACEUTICALS INC	$2.39B	-96.00%	-55.00%	-61.33%	-88.40%	0.96	5.58	88.00%	-238.50%	-219.85%
ARDX	ARDELYX INC	$1.50B	-43.60%	-26.00%	-24.50%	-31.10%	0.78	4.88	85.70%	-53.10%	-48.67%
SPRB	SPRUCE BIOSCIENCES INC	$28.89M	-52.30%	-39.80%	-59.68%	-459.90%	0.36	4.18	100.00%	-475.00%	-470.18%
BGNE	BEIGENE LTD	$15.09B	-23.10%	-15.30%	-22.52%	-54.70%	0.64	2.32	84.50%	-35.90%	-36.60%
ZYME	ZYMEWORKS INC	$603.36M	-26.20%	-20.30%	-22.71%	-31.70%	0.25	7.41	100.00%	-156.10%	-156.87%
CALT	CALLIDITAS THERAPEUTICS AB	$551.12M	-84.70%	-24.50%	-23.60%	-43.10%	4.55	3.13	95.00%	-38.60%	-28.39%
RVMD	REVOLUTION MEDICINES INC	$5.86B	-38.40%	-33.60%	-22.92%	-59.70%	0.13	13.06	100.00%	-3,768.30%	-3,796.10%
SPRY	ARS PHARMACEUTICALS INC	$797.10M	-22.20%	-21.50%	-23.56%	-33.90%	0.01	96.92	100.00%	-181,216.70%	-181,216.67%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$16.19M	-289.40%	-130.20%	-45.34%	1,418.50%	0.51	3.29	100.00%	-49,087.80%	-9,620.98%
ITOS	ITEOS THERAPEUTICS INC	$378.86M	-18.40%	-16.20%	-17.37%	-24.50%	0.16	13.76	100.00%	-894.30%	-865.66%
VRTX	VERTEX PHARMACEUTICALS INC	$103.52B	22.60%	17.30%	23.06%	69.80%	0.29	3.99	87.20%	36.70%	44.83%
PLRX	PLIANT THERAPEUTICS INC	$716.85M	-31.20%	-29.00%	-33.10%	-33.90%	0.08	17.72	100.00%	-10,211.10%	-10,130.95%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$97.69M	-35.20%	-30.80%	-37.84%	-244.70%	0.15	12.46	100.00%	-9,145.50%	-9,525.44%
EYPT	EYEPOINT PHARMACEUTICALS INC	$820.71M	-61.50%	-33.50%	-23.80%	-1,558.50%	0.33	5.45	89.90%	-153.80%	-150.95%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the top biotech stock with a Zen Score of 75, which is 52 points higher than the biotech industry average of 23. It passed 24 out of 33 due diligence checks and has strong fundamentals. Incyte has seen its stock lose -31.24% over the past year, underperforming other biotech stocks by -7 percentage points.

Incyte has an average 1 year price target of $74.69, an upside of 44.36% from Incyte's current stock price of $51.74.

Incyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Incyte, 23.08% have issued a Strong Buy rating, 23.08% have issued a Buy, 53.85% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second best biotech stock with a Zen Score of 70, which is 47 points higher than the biotech industry average of 23. It passed 23 out of 33 due diligence checks and has strong fundamentals. Harmony Biosciences Holdings has seen its stock lose -9.81% over the past year, overperforming other biotech stocks by 14 percentage points.

Harmony Biosciences Holdings has an average 1 year price target of $37.33, an upside of 27.72% from Harmony Biosciences Holdings's current stock price of $29.23.

Harmony Biosciences Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Harmony Biosciences Holdings, 33.33% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 16.67% have issued a Sell rating, and 16.67% have issued a Strong Sell.

3. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the third best biotech stock with a Zen Score of 66, which is 43 points higher than the biotech industry average of 23. It passed 21 out of 33 due diligence checks and has strong fundamentals. Voyager Therapeutics has seen its stock lose -1.69% over the past year, overperforming other biotech stocks by 22 percentage points.

Voyager Therapeutics has an average 1 year price target of $20.50, an upside of 170.81% from Voyager Therapeutics's current stock price of $7.57.

Voyager Therapeutics stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Voyager Therapeutics, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Carisma Therapeutics (NASDAQ:CARM)

Carisma Therapeutics (NASDAQ:CARM) has an annual dividend yield of N/A, which is N/A percentage points lower than the biotech industry average of 14.18%.

Carisma Therapeutics's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

2. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 53.68%, which is 40 percentage points higher than the biotech industry average of 14.18%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk A S (NYSE:NVO)

Novo Nordisk A S (NYSE:NVO) has an annual dividend yield of 1.09%, which is -13 percentage points lower than the biotech industry average of 14.18%. Novo Nordisk A S's dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk A S's dividend has shown consistent growth over the last 10 years.

Novo Nordisk A S's dividend payout ratio of 38.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.75% in the last day, and down -1% over the last week. Avenue Therapeutics was the among the top losers in the biotechnology industry, dropping -29.85% yesterday.

Avenue Therapeutics shares are trading lower after the company announced a reverse stock split.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. Royalty Pharma has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Royalty Pharma's stock has dropped -21.91% in the past year. It has overperformed other stocks in the biotech industry by 2 percentage points.

2. Voyager Therapeutics (NASDAQ:VYGR)

Voyager Therapeutics (NASDAQ:VYGR) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. Voyager Therapeutics has a valuation score of 100, which is 85 points higher than the biotech industry average of 15. It passed 7 out of 7 valuation due diligence checks.

Voyager Therapeutics's stock has dropped -1.69% in the past year. It has overperformed other stocks in the biotech industry by 22 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. Incyte has a valuation score of 86, which is 71 points higher than the biotech industry average of 15. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has dropped -31.24% in the past year. It has underperformed other stocks in the biotech industry by -7 percentage points.

Are biotech stocks a good buy now?

49.32% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 88.37% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 15.69x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.